|
ZNF770 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.20740001225062E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.3767999962333E-08 |
| Normal-vs-Stage2 |
5.055200E-03 |
| Normal-vs-Stage3 |
1.837030E-04 |
| Normal-vs-Stage4 |
5.228300E-04 |
| Stage1-vs-Stage2 |
8.377600E-01 |
| Stage1-vs-Stage3 |
4.510800E-01 |
| Stage1-vs-Stage4 |
9.796200E-01 |
| Stage2-vs-Stage3 |
7.653200E-01 |
| Stage2-vs-Stage4 |
9.051400E-01 |
| Stage3-vs-Stage4 |
6.615400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45739997847727E-09 |
| Normal-vs-AfricanAmerican |
7.53110000000223E-05 |
| Normal-vs-Asian |
1.517160E-01 |
| Caucasian-vs-AfricanAmerican |
4.620000E-01 |
| Caucasian-vs-Asian |
9.227000E-01 |
| AfricanAmerican-vs-Asian |
8.873000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.60049784326111E-11 |
| Normal-vs-Female |
1.168230E-02 |
| Male-vs-Female |
1.659920E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.815400E-04 |
| Normal-vs-Extreme_Weight |
1.48620005191447E-11 |
| Normal-vs-Obese |
2.141900E-03 |
| Normal-vs-Extreme_Obese |
1.234570E-04 |
| Normal_Weight-vs-Extreme_Weight |
6.808000E-02 |
| Normal_Weight-vs-Obese |
6.638000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.578200E-01 |
| Extreme_Weight-vs-Obese |
1.681890E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.008800E-01 |
| Obese-vs-Extreme_Obese |
4.441400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.771400E-04 |
| Normal-vs-Age(41-60Yrs) |
6.46209999954905E-07 |
| Normal-vs-Age(61-80Yrs) |
1.61409996479733E-09 |
| Normal-vs-Age(81-100Yrs) |
1.61613999999366E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.569000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.634800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.966200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.009800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.925000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.063600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.18070006496873E-11 |
| Normal-VS-Type2 PRCC |
2.257300E-03 |
| Normal-VS-KIRP CIMP |
6.981200E-04 |
| Normal-VS-Unclassified PRCC |
2.228700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.849510E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.620200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.603560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.265000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.650200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.262800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.14910003313452E-09 |
| Normal-vs-N1 |
2.384200E-04 |
| Normal-vs-N2 |
5.576500E-03 |
| N0-vs-N1 |
3.078000E-01 |
| N0-vs-N2 |
9.923600E-01 |
| N1-vs-N2 |
6.675800E-01 |
|
|
